Michiyoshi Kobayashi

835 total citations
9 papers, 708 citations indexed

About

Michiyoshi Kobayashi is a scholar working on Pharmacology, Organic Chemistry and Oncology. According to data from OpenAlex, Michiyoshi Kobayashi has authored 9 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Michiyoshi Kobayashi's work include Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Michiyoshi Kobayashi is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Michiyoshi Kobayashi collaborates with scholars based in Japan, United States and United Kingdom. Michiyoshi Kobayashi's co-authors include Takayuki Maruyama, Shuh Narumiya, Yukihiko Sugimoto, Shuichi Ohuchida, Kousuke Tani, Tomohiro Kitamura, Takashi Sügimura, Kaoru Kobayashi, Keiji Wakabayashi and Hirahito Endo and has published in prestigious journals such as The Journal of Experimental Medicine, Bioorganic & Medicinal Chemistry and Cancer Science.

In The Last Decade

Michiyoshi Kobayashi

9 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michiyoshi Kobayashi Japan	8	504	258	207	148	127	9	708
Simon Chell United Kingdom	7	216 0.4×	110 0.4×	244 1.2×	145 1.0×	100 0.8×	8	531
Xiping Xin Canada	12	140 0.3×	80 0.3×	360 1.7×	243 1.6×	153 1.2×	17	776
Yoji Taba Japan	12	201 0.4×	67 0.3×	404 2.0×	87 0.6×	97 0.8×	16	698
Jean‐Luc Burgaud France	14	85 0.2×	73 0.3×	384 1.9×	98 0.7×	99 0.8×	21	769
Thomas R. Hundley United States	12	136 0.3×	52 0.2×	142 0.7×	32 0.2×	37 0.3×	14	477
Vasan Yegnasubramanian United States	2	186 0.4×	85 0.3×	279 1.3×	91 0.6×	63 0.5×	3	515
Rivka Hadar Israel	17	208 0.4×	53 0.2×	312 1.5×	139 0.9×	126 1.0×	37	841
Mirna Sirinyan Canada	9	140 0.3×	63 0.2×	319 1.5×	71 0.5×	58 0.5×	10	933
Christopher Fletcher United Kingdom	3	167 0.3×	77 0.3×	656 3.2×	123 0.8×	349 2.7×	4	746
Chang‐Hun Rhee South Korea	13	58 0.1×	39 0.2×	384 1.9×	107 0.7×	114 0.9×	17	601

Countries citing papers authored by Michiyoshi Kobayashi

Since Specialization

Citations

This map shows the geographic impact of Michiyoshi Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiyoshi Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiyoshi Kobayashi more than expected).

Fields of papers citing papers by Michiyoshi Kobayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiyoshi Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiyoshi Kobayashi. The network helps show where Michiyoshi Kobayashi may publish in the future.

Co-authorship network of co-authors of Michiyoshi Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Michiyoshi Kobayashi. A scholar is included among the top collaborators of Michiyoshi Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiyoshi Kobayashi. Michiyoshi Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Frankle, W. Gordon, Rajesh Narendran, Fumitaka Suto, et al.. (2017). Brain translocator protein occupancy by ONO‐2952 in healthy adults: A Phase 1 PET study using [¹¹C]PBR28. Synapse. 71(7). 7 indexed citations

Suto, Fumitaka, et al.. (2015). Safety, Tolerability, and Pharmacokinetic Profile of the Novel Translocator Protein 18 kDa Antagonist ONO-2952 in Healthy Volunteers. Clinical Therapeutics. 37(9). 2071–2084. 8 indexed citations

Kobayashi, T., et al.. (2006). Effects of N-alkyl and ammonium groups on the hydrolytic cleavage of DNA with a Cu(II)TACH (1,3,5-triaminocyclohexane) complex. Speciation, kinetic, and DNA-binding studies for reaction mechanism. Journal of Inorganic Biochemistry. 101(2). 348–361. 28 indexed citations

Naganawa, Atsushi, Hiroshi Yamamoto, Michiyoshi Kobayashi, et al.. (2006). Discovery of new chemical leads for selective EP1 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(16). 5562–5577. 13 indexed citations

Kitamura, Tomohiro, Masaki Itoh, Tetsuo Noda, et al.. (2003). Combined effects of prostaglandin E receptor subtype EP₁ and subtype EP₄ antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Science. 94(7). 618–621. 42 indexed citations

Amano, Hideki, Izumi Hayashi, Hirahito Endo, et al.. (2003). Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth. The Journal of Experimental Medicine. 197(2). 221–232. 283 indexed citations

Mutoh, Michihiro, Kouji Watanabe, Tomohiro Kitamura, et al.. (2002). Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.. PubMed. 62(1). 28–32. 304 indexed citations

Maruyama, Takayuki, Hiroshi Yamamoto, Michiyoshi Kobayashi, et al.. (1999). Novel two types of orally active EP1 receptor antagonists. Prostaglandins & Other Lipid Mediators. 59(1-6). 216–216. 1 indexed citations

Yamamoto, Hiroshi, Takayuki Maruyama, Kiyoto Sakata, et al.. (1999). Novel four selective agonists for prostaglandin E receptor subtypes. Prostaglandins & Other Lipid Mediators. 59(1-6). 150–150. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact